Warning: The NCBI web site requires JavaScript to function. more...
Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.
Kopciuk KA, Choi YH, Parkhomenko E, Parfrey P, McLaughlin J, Green J, Briollais L.
Hered Cancer Clin Pract. 2009 Oct 28;7(1):16.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.
Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.
Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario.
Choi YH, Cotterchio M, McKeown-Eyssen G, Neerav M, Bapat B, Boyd K, Gallinger S, McLaughlin J, Aronson M, Briollais L.
Hered Cancer Clin Pract. 2009 Aug 23;7(1):14.
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS.
Oncologist. 1996;1(5):326-330.
Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.
Lin KM, Shashidharan M, Thorson AG, Ternent CA, Blatchford GJ, Christensen MA, Watson P, Lemon SJ, Franklin B, Karr B, Lynch J, Lynch HT.
J Gastrointest Surg. 1998 Jan-Feb;2(1):67-71.
Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation.
Green J, O'Driscoll M, Barnes A, Maher ER, Bridge P, Shields K, Parfrey PS.
Dis Colon Rectum. 2002 Sep;45(9):1223-32.
Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.
Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin JP, de la Chapelle A.
Gastroenterology. 2005 Aug;129(2):415-21.
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB.
Gastroenterology. 2009 Nov;137(5):1621-7. Epub 2009 Jul 18.
A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
Froggatt NJ, Green J, Brassett C, Evans DG, Bishop DT, Kolodner R, Maher ER.
J Med Genet. 1999 Feb;36(2):97-102.
Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG.
Clin Genet. 2008 Sep;74(3):233-42. Epub 2008 Jun 28.
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.
Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL.
J Natl Cancer Inst. 2002 Sep 18;94(18):1365-72.
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.
Estimating cancer risk in HNPCC by the GRL method.
Alarcon F, Lasset C, Carayol J, Bonadona V, Perdry H, Desseigne F, Wang Q, Bonaïti-Pellié C.
Eur J Hum Genet. 2007 Aug;15(8):831-6. Epub 2007 May 2.
MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, Taal BG, Moller P, Wijnen JT.
J Clin Oncol. 2001 Oct 15;19(20):4074-80.
The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome.
Stuckless S, Parfrey PS, Woods MO, Cox J, Fitzgerald GW, Green JS, Green RC.
Fam Cancer. 2007;6(1):1-12.
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC, Durocher F, Smith P, Simard J, Easton DF; INHERIT BRCAs program members.
Breast Cancer Res. 2006;8(1):R3. Epub 2005 Dec 12.
Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.
J Natl Cancer Inst. 2006 Jan 18;98(2):116-22.
Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).
Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ, Fisher S, Hodgson SV.
Fam Cancer. 2008;7(2):163-72. Epub 2007 Oct 16.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on